CompletedNot Applicable

The Effect of Priming Intravenous Rocuronium on Fentanyl-Induced Coughing

Taiwan260 participantsStarted 2011-03

Plain-language summary

An intravenous bolus of fentanyl often induces a cough reflex. This study investigates whether priming with rocuronium can attenuate fentanyl-induced coughing effectively.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 260 ASA I-II patients, * aged between 18 and 80 years, and undergoing various elective surgeries at Taichung Armed Forces General Hospital. Exclusion Criteria: * a history of asthma, * chronic cough, * smoking, * upper respiratory tract infection in the previous 2 weeks, and * medication containing angiotensin-converting enzyme inhibitors or anesthetic premedication.

What they're measuring

Incidence of fentanyl-induced coughing

Timeframe: 2 minutes

Trial details

NCT IDNCT01532466

SponsorTaichung Armed Forces General Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2011-10

View on ClinicalTrials.gov More Fentanyl-induced Coughing trials